DALAFAR CAP. 300 MG. CAJA C/16 OTILONIO BROMURO PRINCIPIO ACTIVO: DOXAZOSINA MESILATO

Description

PRINCIPIO ACTIVO: DOXAZOSINA MESILATO

ayudando a disminuir la urgencia urinaria

Factor VIII recombinante humano 2000 UI

PRINCIPIO ACTIVO: LIDAMIDINA CLORHIDRATO

hemorragia digestiva reciente

DALAFAR CAP. 300 MG. CAJA C/16 OTILONIO BROMURO PRINCIPIO ACTIVO: DOXAZOSINA MESILATOSUSTANCIA: DALAFAR CAP. 300 MG. CAJA C 16 FABRICANTE: SYNTHON

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy